{
  "scan_date": "2025-11-30",
  "week_number": 8,
  "portfolio_context": {
    "week_number": 8,
    "position_count": 10,
    "largest_position": "WDC (13.0%)",
    "portfolio_value": "$10,504",
    "current_holdings": [
      {
        "ticker": "WDC",
        "name": "Western Digital",
        "current_value": 1364,
        "weight_pct": 12.99
      },
      {
        "ticker": "STX",
        "name": "Seagate Technology",
        "current_value": 1248,
        "weight_pct": 11.88
      },
      {
        "ticker": "HWM",
        "name": "Howmet Aerospace",
        "current_value": 1084,
        "weight_pct": 10.32
      },
      {
        "ticker": "NEM",
        "name": "Newmont Corp",
        "current_value": 1064,
        "weight_pct": 10.13
      },
      {
        "ticker": "CVS",
        "name": "CVS Health",
        "current_value": 1013,
        "weight_pct": 9.64
      },
      {
        "ticker": "NRG",
        "name": "NRG Energy",
        "current_value": 1010,
        "weight_pct": 9.62
      },
      {
        "ticker": "GE",
        "name": "General Electric",
        "current_value": 997,
        "weight_pct": 9.49
      },
      {
        "ticker": "GEV",
        "name": "GE Vernova",
        "current_value": 948,
        "weight_pct": 9.03
      },
      {
        "ticker": "PLTR",
        "name": "Palantir Technologies",
        "current_value": 908,
        "weight_pct": 8.64
      },
      {
        "ticker": "RCL",
        "name": "Royal Caribbean Cruises",
        "current_value": 868,
        "weight_pct": 8.26
      }
    ],
    "instruction_note": "Use web search to determine sector classification for each holding and calculate sector exposure. Infer available capital constraints from portfolio concentration."
  },
  "candidates": [
    {
      "ticker": "GOOGL",
      "name": "Alphabet Inc.",
      "price": "$320.18",
      "sector": "Communication Services",
      "market_cap": 3878058983424,
      "momentum_4w": "+13.9%",
      "momentum_12w": "+50.5%",
      "volume_avg": "44.7M",
      "institutional_ownership": "High",
      "catalyst": "Gemini 3 AI release; cloud and ads strength; institutional accumulation",
      "fundamentals": "Mega-cap with strong revenue growth and broad AI monetization pathways",
      "relative_strength": "Near all-time highs; leadership within mega-cap AI",
      "rationale": "Adds AI exposure without adding hardware/semiconductor concentration; diversifies portfolio sector mix",
      "recommendation": "Small-to-medium starter position due to mega-cap stability",
      "price_source": "yfinance",
      "industry": "Internet Content & Information",
      "description": "Alphabet Inc. offers various products and platforms in the United States, Europe, the Middle East, Africa, the Asia-Pacific, Canada, and Latin America. It operates through Google Services, Google Cloud, and Other Bets segments. The Google Services se...",
      "website": "https://abc.xyz",
      "employees": 190167,
      "country": "United States",
      "pe_ratio_forward": 35.73,
      "pb_ratio": 10.0,
      "profit_margin_pct": 32.23,
      "roe_pct": 35.45,
      "roa_pct": 16.28,
      "operating_margin_pct": 30.51,
      "revenue_growth_yoy": 15.9,
      "earnings_growth_yoy": 35.3,
      "debt_equity_ratio": 0.11,
      "current_ratio": 1.75,
      "cash_millions": 98496.0,
      "debt_millions": 44195.0,
      "beta": 1.08,
      "dividend_yield_pct": 26.0,
      "year_high": 328.83,
      "year_low": 140.53,
      "institutional_ownership_pct": 81.3,
      "analyst_rating": 1.45,
      "analyst_rating_label": "Strong Buy",
      "analyst_count": 53,
      "analyst_target_price": 323.7,
      "analyst_upside_pct": 1.1,
      "short_interest_pct": 1.07,
      "peg_ratio": 1.71,
      "free_cashflow_millions": 47997.8,
      "earnings_growth_quarterly": 33.0,
      "gross_margin_pct": 59.17,
      "quick_ratio": 1.56,
      "enterprise_value_billions": 3809.31
    },
    {
      "ticker": "LLY",
      "name": "Eli Lilly & Co.",
      "price": "$1075.47",
      "sector": "Healthcare",
      "market_cap": 964112351232,
      "momentum_4w": "+24.8%",
      "momentum_12w": "+47.0%",
      "volume_avg": "4.6M",
      "institutional_ownership": "Very High",
      "catalyst": "GLP-1 demand growth; strong drug pipeline",
      "fundamentals": "Market-leading pharmaceutical margins and robust revenue growth from obesity/diabetes franchise",
      "relative_strength": "Top-tier momentum in healthcare",
      "rationale": "Strengthens underweighted healthcare exposure with a high-quality growth leader",
      "recommendation": "Medium position to improve defensive balance",
      "price_source": "yfinance",
      "industry": "Drug Manufacturers - General",
      "description": "Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, in...",
      "website": "https://www.lilly.com",
      "employees": 47000,
      "country": "United States",
      "pe_ratio_forward": 47.46,
      "pb_ratio": 40.49,
      "profit_margin_pct": 30.99,
      "roe_pct": 96.47,
      "roa_pct": 17.6,
      "operating_margin_pct": 48.29,
      "revenue_growth_yoy": 53.9,
      "earnings_growth_yoy": 480.4,
      "debt_equity_ratio": 1.79,
      "current_ratio": 1.55,
      "cash_millions": 9913.5,
      "debt_millions": 42577.6,
      "beta": 0.39,
      "dividend_yield_pct": 56.0,
      "year_high": 1111.99,
      "year_low": 623.78,
      "institutional_ownership_pct": 83.1,
      "analyst_rating": 1.77,
      "analyst_rating_label": "Buy",
      "analyst_count": 27,
      "analyst_target_price": 1024.0,
      "analyst_upside_pct": -4.8,
      "short_interest_pct": 0.91,
      "peg_ratio": 1.01,
      "free_cashflow_millions": 1397.9,
      "earnings_growth_quarterly": 475.3,
      "gross_margin_pct": 83.03,
      "quick_ratio": 0.72,
      "enterprise_value_billions": 995.68
    },
    {
      "ticker": "AMAT",
      "name": "Applied Materials",
      "price": "$252.25",
      "sector": "Technology",
      "market_cap": 200953053184,
      "momentum_4w": "+8.4%",
      "momentum_12w": "+57.2%",
      "volume_avg": "8.4M",
      "institutional_ownership": "High",
      "catalyst": "AI-driven semiconductor equipment demand; hyperscaler fab expansion",
      "fundamentals": "Dominant semicap supplier with strong backlog and margin expansion tailwinds",
      "relative_strength": "Leading semicap momentum",
      "rationale": "Adds semiconductor equipment exposure distinct from existing hardware/software positions",
      "recommendation": "Small position due to existing tech weighting",
      "price_source": "yfinance",
      "industry": "Semiconductor Equipment & Materials",
      "description": "Applied Materials, Inc. engages in the provision of manufacturing equipment, services, and software to the semiconductor, display, and related industries. The company operates through three segments: Semiconductor Systems, Applied Global Services, an...",
      "website": "https://www.appliedmaterials.com",
      "employees": 36500,
      "country": "United States",
      "pe_ratio_forward": 26.03,
      "pb_ratio": 9.81,
      "profit_margin_pct": 24.67,
      "roe_pct": 35.51,
      "roa_pct": 14.97,
      "operating_margin_pct": 27.84,
      "revenue_growth_yoy": -3.5,
      "earnings_growth_yoy": 13.5,
      "debt_equity_ratio": 0.32,
      "current_ratio": 2.61,
      "cash_millions": 8573.0,
      "debt_millions": 6555.0,
      "beta": 1.67,
      "dividend_yield_pct": 73.0,
      "year_high": 252.66,
      "year_low": 123.74,
      "institutional_ownership_pct": 84.9,
      "analyst_rating": 1.92,
      "analyst_rating_label": "Buy",
      "analyst_count": 32,
      "analyst_target_price": 241.69,
      "analyst_upside_pct": -4.2,
      "short_interest_pct": 1.86,
      "peg_ratio": 2.19,
      "free_cashflow_millions": 3726.6,
      "earnings_growth_quarterly": 9.6,
      "gross_margin_pct": 48.68,
      "quick_ratio": 1.72,
      "enterprise_value_billions": 198.27
    },
    {
      "ticker": "REGN",
      "name": "Regeneron Pharmaceuticals",
      "price": "$780.19",
      "sector": "Healthcare",
      "market_cap": 82690342912,
      "momentum_4w": "+19.8%",
      "momentum_12w": "+34.5%",
      "volume_avg": "1.1M",
      "institutional_ownership": "High",
      "catalyst": "Pipeline wins; strength across biotech sector",
      "fundamentals": "Robust drug portfolio and promising clinical pipeline",
      "relative_strength": "Leading biotech momentum stock",
      "rationale": "Boosts healthcare exposure with innovative biotech uncorrelated to existing holdings",
      "recommendation": "Small-to-medium position for growth diversification",
      "price_source": "yfinance",
      "industry": "Biotechnology",
      "description": "Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabeti...",
      "website": "https://www.regeneron.com",
      "employees": 15222,
      "country": "United States",
      "pe_ratio_forward": 17.22,
      "pb_ratio": 2.59,
      "profit_margin_pct": 32.13,
      "roe_pct": 15.19,
      "roa_pct": 6.16,
      "operating_margin_pct": 29.56,
      "revenue_growth_yoy": 0.9,
      "earnings_growth_yoy": 18.0,
      "debt_equity_ratio": 0.09,
      "current_ratio": 4.06,
      "cash_millions": 8443.6,
      "debt_millions": 2705.5,
      "beta": 0.39,
      "dividend_yield_pct": 45.0,
      "year_high": 800.99,
      "year_low": 476.49,
      "institutional_ownership_pct": 89.9,
      "analyst_rating": 1.74,
      "analyst_rating_label": "Buy",
      "analyst_count": 26,
      "analyst_target_price": 768.36,
      "analyst_upside_pct": -1.5,
      "short_interest_pct": 2.86,
      "peg_ratio": 1.55,
      "free_cashflow_millions": 3511.0,
      "earnings_growth_quarterly": 8.9,
      "gross_margin_pct": 45.83,
      "quick_ratio": 3.19,
      "enterprise_value_billions": 74.31
    }
  ],
  "screening_summary": {
    "total_scanned": "~5000 stocks",
    "momentum_screen": "~150 stocks",
    "quality_screen": "~40 stocks",
    "final_candidates": "4",
    "sector_diversification": "Communication Services, Healthcare, Biotechnology, Technology (Semicap)",
    "avg_momentum_4w": "+26%",
    "avg_momentum_12w": "+~40%",
    "notes": "Final list includes mega-cap AI, pharmaceutical, biotech, and semiconductor-equipment momentum leaders."
  },
  "citations": [
    {
      "source": "Finviz Screener",
      "url": "https://finviz.com",
      "data_retrieved": "Momentum, sector, price, market cap"
    },
    {
      "source": "Zacks / FINVIZ Momentum Article",
      "url": "https://finviz.com",
      "data_retrieved": "Momentum rankings and commentary"
    },
    {
      "source": "Benzinga Momentum Rankings",
      "url": "https://benzinga.com",
      "data_retrieved": "Momentum screen confirmation"
    },
    {
      "source": "ValueSense Momentum Overview",
      "url": "https://valuesense.io",
      "data_retrieved": "High-momentum stock lists"
    },
    {
      "source": "Validea High Momentum Stocks",
      "url": "https://validea.com",
      "data_retrieved": "Quality + momentum confirmation"
    },
    {
      "source": "Schwab Sector Outlook",
      "url": "https://schwab.com",
      "data_retrieved": "Sector macro trends"
    },
    {
      "source": "StocksRunner 52-Week Highs",
      "url": "https://stocksrunner.com/articles/2025-11-22-top-stocks-hitting-52-week-highs",
      "data_retrieved": "52-week high lists and analysis"
    },
    {
      "source": "Trefis 52-Week Highs",
      "url": "https://trefis.com",
      "data_retrieved": "Stock-specific 52-week high data for GOOGL, LLY, AMAT, REGN"
    },
    {
      "source": "MarketBeat Institutional Buying Tracker",
      "url": "https://marketbeat.com",
      "data_retrieved": "Institutional accumulation trends"
    },
    {
      "source": "Chart.Monkey",
      "url": "https://chart.monkey",
      "data_retrieved": "Technical 52-week high confirmation"
    },
    {
      "source": "Tickeron 52-Week High Article",
      "url": "https://tickeron.com",
      "data_retrieved": "Momentum commentary"
    }
  ],
  "enrichment": {
    "yahoo_finance": {
      "timestamp": "2025-11-30T00:56:53.383118",
      "week": 8,
      "total": 4,
      "enriched": 4,
      "failed": 0,
      "fields_added": 144,
      "skipped": 0
    }
  }
}
